VIMTA LABS
Back to Income Statement
|
VIMTA LABS Last 5 Year Revenue History
[Consolidated]
| Mar2024 | Mar2023 | Mar2022 | Mar2021 | Mar2020 | |
|---|---|---|---|---|---|
| Net Sales | ₹318 Cr | ₹318 Cr | ₹278 Cr | ₹211 Cr | ₹181 Cr |
What is the latest Revenue of VIMTA LABS ?
| Year | Revenue |
|---|---|
| Mar2024 | ₹318 Cr |
| Mar2023 | ₹318 Cr |
| Mar2022 | ₹278 Cr |
| Mar2021 | ₹211 Cr |
| Mar2020 | ₹181 Cr |
How is Revenue of VIMTA LABS Trending?
| Years | Revenue | % Change | |
|---|---|---|---|
| Mar2024 | ₹318 Cr | 0.02 | |
| Mar2023 | ₹318 Cr | 14.34 | |
| Mar2022 | ₹278 Cr | 32.09 | |
| Mar2021 | ₹211 Cr | 16.58 | |
| Mar2020 | ₹181 Cr | - | |
Compare Revenue of peers of VIMTA LABS
| Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
| VIMTA LABS | ₹2,687.6 Cr | 0.9% | -1.6% | 24.4% | Stock Analytics | |
| SUN PHARMACEUTICAL INDUSTRIES | ₹412,086.0 Cr | -1.5% | -4.8% | -4.2% | Stock Analytics | |
| DIVIS LABORATORIES | ₹169,616.0 Cr | -1.9% | -1.6% | 11.1% | Stock Analytics | |
| TORRENT PHARMACEUTICALS | ₹128,361.0 Cr | 0.3% | 1.6% | 12.1% | Stock Analytics | |
| CIPLA | ₹120,713.0 Cr | -1.2% | -2% | 2% | Stock Analytics | |
| DR REDDYS LABORATORIES | ₹105,881.0 Cr | -1.2% | 1.5% | -6.1% | Stock Analytics | |
VIMTA LABS Share Price vs Sensex
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| VIMTA LABS | 0.9% |
-1.6% |
24.4% |
| SENSEX | -0.3% |
-1.1% |
7.8% |
You may also like the below Video Courses